Alternative treatment for cholesterol shows promise


  • Business Premium
  • Monday, 31 Mar 2014

WASHINGTON: An experimental treatment has shown promise in lowering bad cholesterol, offering hope for people at risk of heart disease but who cannot tolerate drugs known as statins, researchers said Sunday.

Evolocumab is part of a new class of drugs known as PCSK9 inhibitors, which suppress a gene involved with cholesterol regulation in the liver.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Business News

Asian stocks eke out gains as slowdown concerns linger Premium
Oil prices edge higher on tight supply, firmer demand expectations Premium
Malaysia setting up centre for 4IR to spur economy recovery Premium
Hibiscus Petroleum's 3Q net profit jumps to RM307.54mil, declares 1c div per share Premium
T7 Global posts net profit of RM2.72mil in 1Q Premium
Malaysia's recovery continues to be resilient, March's LI up to 111.3 points Premium
Bumi Armada posts improved 1Q net profit of RM185.76mil Premium
FBM KLCI stays positive as Asia shrugs off Wall St weakness Premium
CPI rises 2.3% in April, with food inflation higher at 4.1% Premium
Elon Musk drops out of US$200bil club again as Tesla tumbles Premium

Others Also Read